Journal
CANCER CYTOPATHOLOGY
Volume 128, Issue 5, Pages 309-316Publisher
WILEY
DOI: 10.1002/cncy.22280
Keywords
biosafety; coronavirus; COVID-19; cytology; pneumonia
Ask authors/readers for more resources
This commentary focuses on the cytopathology laboratory, the authors' experiences with coronavirus (COVID-19) in Taiwan, and current guidelines on COVID-19 infection prevention and control. The objective of this report is to provide cytopathology professionals a timely, in-depth, evidence-based review of biosafety practices for those at risk for coronavirus (COVID-19) infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available